Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells
Radioiodine is a routine therapy for differentiated thyroid cancers. Non-thyroid cancers can intake radioiodine after transfection of the human sodium iodide symporter (hNIS) gene. The human telomerase reverse transcriptase (hTERT) promoter, an excellent tumor-specific promoter, has potential value...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Sun Yat-sen University Cancer Center
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013408/ |